Sg Americas Securities, LLC Ikena Oncology, Inc. Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024
SELL
$1.27 - $2.0 $9,819 - $15,464
-7,732 Reduced 38.24%
12,490 $18,000
Q4 2023

Jan 12, 2024
BUY
$1.33 - $4.4 $12,628 - $41,778
9,495 Added 88.51%
20,222 $40,000
Q3 2023

Oct 13, 2023
BUY
$4.09 - $6.43 $43,873 - $68,974
10,727 New
10,727 $46,000
Q1 2022

Apr 29, 2022
SELL
$5.61 - $13.85 $52,470 - $129,539
-9,353 Closed
0 $0
Q4 2021

Feb 07, 2022
BUY
$10.52 - $16.96 $98,393 - $158,626
9,353 New
9,353 $117,000

Others Institutions Holding IKNA

# of Institutions
61
Shares Held
30.6M
Call Options Held
0
Put Options Held
0
View Full List

About Ikena Oncology, Inc.

IKNA Quotes by TradingView
  • Ticker IKNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,257,500
  • Market Cap $56.9M
  • Description
  • Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...
More about IKNA
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email